Reynolds, Tyelor S.
Mishra, Sanket J.
Blagg, Brian S. J.
Funding for this research was provided by:
National Institutes of Health (DA052340)
National Institutes of Health (DA052340)
Article History
Received: 11 October 2024
Accepted: 13 January 2025
First Online: 29 January 2025
Declarations
:
: SM and BB are co-founders of Grannus Therapeutics Inc., a company that aims to bring Hsp90b-selective inhibitors to the clinic for the treatment of cancer. TR is not associated with Grannus Therapeutics Inc.